Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall/CRC Biostatistics)
Language: English
Published by Chapman and Hall/CRC 2024-05-27, 2024
- Softcover
- New

Seller: Chiron Media, Wallingford, United KingdomChiron Media
AbeBooks seller since August 2, 2010
Condition: New
US$ 74.18
Quantity: 5 available
Add to basketItem description from seller
Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.
Seller Inventory # 6666-TNFPD-9780367609955
- Title
- Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall/CRC Biostatistics)
- Author
- Wei Zhang, Shein-Chung Chow, Fangrong Yan, Feng Chen
- Publisher
- Chapman and Hall/CRC 2024-05-27
- Publication year
- 2024
- Condition
- New
- Binding
- Paperback
- Language
- English
- ISBN 10
- 0367609959
- ISBN 13
- 9780367609955
- Series
- Book 133 of 155: Chapman & Hall/CRC Biostatistics
Advanced Statistics in Regulatory Critical Clinical Initiatives is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development. Advanced Statistics in Regulatory Critical Clinical Initiatives provides innovative ways to resolve common challenges in statistical research of rare diseases such small sample sizes and provides guidance for combined use of data. With analysis from regulatory and scientific perspectives this book is an ideal companion for researchers in biostatistics, pharmaceutical development, and policy makers in related fields.
Key Features:
- Provides better understanding of innovative design and analysis of each critical clinical initiatives which may be used in regulatory review/approval of drug development.
- Makes recommendations to evaluate submissions accurately and reliably.
- Proposes innovative study designs and statistical methods for oncology and/or rare disease drug development.
- Provides insight regarding current regulatory guidance on drug development such as gene therapy and rare diseases.
"Synopsis" may belong to another edition of this title.
About the Author
Wei Zhang is the Vice President, Head of Biometrics at AffaMed Therapeutics, New York.
Fangrong Yan is a Professor of Biostatistics in the School of Science, and Director of Biostatistics and Computational Pharmacy Research Center at China Pharmaceutical University (CPU).
Feng Chen is a Professor of Biostatistics in School of Public Health, Nanjing Medical University (NJMU).
Shein-Chung Chow is currently a Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham.
"About the title" may belong to another edition of this title.
Chiron Media
Wallingford, United Kingdom
AbeBooks seller since August 2, 2010
Shipping rates from United Kingdom to U.S.A.
| Item | 24 to 38 business days | 24 to 38 business days |
|---|---|---|
| First item | US$ 8.53 | US$ 8.53 |
Payment methods
Seller's business information
WRAP Ltd
Unit 4, 119 Loverock Rd
Reading, United Kingdom RG30 1DZ
Terms of sale
TBA
Shipping terms
Shipping costs are based on books weighing 2.2 LB, or 1 KG. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.